» Articles » PMID: 17828713

Pharmacokinetics of Diclofenac in Rats Intoxicated with CCL4, and in the Regenerating Liver

Overview
Publisher Wiley
Date 2007 Sep 11
PMID 17828713
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of an intravenous and oral diclofenac dose of 3.2 mg/kg was studied in male Wistar rats under control conditions, 1 and 3 days after liver damage and regeneration induced by an oral injection of CCl(4). One day after CCl(4) administration, indicators of necrosis (alanine aminotransferase), cholestasis (gamma-glutamyl transpeptidase) and regeneration (alpha-fetoprotein) were significantly increased; these effects were reversed after 3 days. In nonintoxicated rats, t(1/2) was 43.83 +/- 4.95 min, V(d) was 0.37 +/- 0.04 l/kg, Cl was 129.21 +/- 9.20 ml/min kg, AUC(i.v.) was 25.62 +/- 1.45 microg/min ml, and AUC(p.o.) was 20.21 +/- 1.03. One day after intoxication, when the liver was damaged and regenerating, the metabolism was decreased: diclofenac t(1/2) was increased to 258.21 +/- 30.80 min but V(d) did not change significantly, therefore Cl was reduced to 32.81 +/- 3.38 ml/min kg. By day 3 after intoxication, liver function, regeneration and pharmacokinetics returned to normal. The results show that liver damage and regeneration increases the bioavailability by decreasing elimination. The present observations suggest that reduction of the pharmacokinetic parameters may lead to drug accumulation in the regenerating-damaged liver with an attendant possible increase in toxic effects. The results in rats, also suggest that once hepatic injury is finished and regeneration is complete, diclofenac can be administered normally.

Citing Articles

Protective impacts of leaf extract from Taif area against induced hepato-renal toxicity: role of antioxidants, inflammation, apoptosis, and anti-oxidative stress biomarkers.

Soliman M, Elshehawei A, Althobaiti S, Sayed S Toxicol Res (Camb). 2023; 12(4):685-692.

PMID: 37663806 PMC: 10470349. DOI: 10.1093/toxres/tfad058.


Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo.

Kim S, Kim K, Ryu H, Hong S, Kim B, Kim D Molecules. 2018; 23(6).

PMID: 29914211 PMC: 6100004. DOI: 10.3390/molecules23061470.


Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies.

Schebb N, Inceoglu B, Rose T, Wagner K, Hammock B Anal Methods. 2011; 3(2):420-428.

PMID: 21660124 PMC: 3110015. DOI: 10.1039/C0AY00714E.


Diclofenac and ketoprofen liver toxicity in rat.

Tomic Z, Milijasevic B, Sabo A, Dusan L, Jakovljevic V, Mikov M Eur J Drug Metab Pharmacokinet. 2009; 33(4):253-60.

PMID: 19230600 DOI: 10.1007/BF03190881.